Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$345K Hold
6,333
0.09% 136
2022
Q1
$345K Sell
6,333
-1,600
-20% -$86.9K 0.07% 149
2021
Q4
$437K Buy
+7,933
New +$413K 0.08% 138
2020
Q4
Sell
-8,200
Closed -$386K 162
2020
Q3
$386K Buy
+8,200
New +$411K 0.15% 102

Other funds holding GSK

Minot Wealth Management's GSK Position: Q2 2022 in Review

Minot Wealth Management held its GSK (GSK) position steady in Q2 2022 at 6,333 shares worth $345K. The position accounts for 0.09% of the portfolio, ranked #136.

Minot Wealth Management first reported a position in GSK in Q3 2020 and has held it in 4 quarters since. The position peaked at $437K in Q4 2021. 901 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • Minot Wealth Management held 6,333 shares of GSK worth $345K as of Q2 2022.
  • Minot Wealth Management left its GSK share count unchanged in Q2 2022.
  • GSK made up 0.09% of Minot Wealth Management's portfolio in Q2 2022, its #136 holding.
  • Minot Wealth Management first reported a position in GSK in Q3 2020 and has held it in 4 quarters since.
  • Minot Wealth Management's GSK position peaked at $437K in Q4 2021.
  • 901 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.